Researchers seeking participants
From time to time the MS Trust is asked by organisations to share information about studies that are about to start, or have started, or are wanting to recruit people. These organisations include pharma companies, companies working on their behalf known as Clinical Research Organisations, healthcare professionals and academic researchers.
In the event of this happening and in the interest of people with MS the MS Trust will seek confirmation from the organisation or individual that the study has the appropriate ethical approval and that any information or advert that we are being asked to share with you has ethical approval. In addition we will ensure that contact details are obtained should further information be required.
This is the only action that the MS Trust will take and we assume no further responsibility for the information shown.
Please note if you do require any further information about items posted here please use the contact details provided. The MS Trust has no further information and should not be contacted.
Clinical trial of a new drug under development by Apitope Technology
April 2010
ATX-MS-1467 is a new drug under development by Apitope Technology (Bristol) Ltd as a potential new treatment for patients with relapsing multiple sclerosis.
Researchers are currently seeking 18-55 year old male and female patients with relapsing remitting MS to join in the trial currently underway at several study sites in the UK.
Patient research cohort – rapidly evolving multiple sclerosis
March 2010
Do you have multiple sclerosis (MS)?
Or do you know somebody who has MS?
If YES, Imperial College London is recruiting for participants in research into availability and access to MS clinical trials.
Study on adolescents with a parent with MS
January 2010
Researchers at the University of Southampton are carrying out a research project to understand how adolescents adjust to their parent's MS. In particular, they would like to see what factors are linked to how well adolescents cope.
